We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$950M
(+7.4%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$45.6M |
| 2 |
Accenture
ACN
|
+$41.1M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.7M |
| 4 |
Hormel Foods
HRL
|
+$32.9M |
| 5 |
PACCAR
PCAR
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$61.7M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$23.5M |
| 3 |
ORB
ORBITAL SCIENCES CORP
ORB
|
+$21.2M |
| 4 |
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
|
+$21.1M |
| 5 |
Hope Bancorp
HOPE
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.9T
| $262M | 1.91% |
8,431,208
+655,844
| +8% | +$19.8M |
|
2
Johnson & Johnson
JNJ
$633B
| $247M | 1.8% |
2,454,759
+13,192
| +0.5% | +$1.34M |
|
3
ExxonMobil
XOM
$649B
| $234M | 1.71% |
2,756,301
+195,948
| +8% | +$17.4M |
|
4
Procter & Gamble
PG
$343B
| $140M | 1.02% |
1,705,704
+15,521
| +0.9% | +$1.33M |
|
5
Chevron
CVX
$387B
| $134M | 0.97% |
1,272,345
+994
| +0.1% | +$106K |
|
6
Home Depot
HD
$330B
| $128M | 0.93% |
1,125,334
-7,921
| -0.7% | -$874K |
|
7
Oracle
ORCL
$341B
| $124M | 0.9% |
2,872,108
+239,350
| +9% | +$10.4M |
|
8
PepsiCo
PEP
$185B
| $119M | 0.87% |
1,248,005
+56,443
| +5% | +$5.46M |
|
9
3M
MMM
$88.7B
| $117M | 0.85% |
845,480
-1,819
| -0.2% | -$251K |
|
10
Automatic Data Processing
ADP
$99.2B
| $110M | 0.8% |
1,282,023
+176,767
| +16% | +$15.2M |
|
|
11
Accenture
ACN
$88.9B
| $107M | 0.78% |
1,143,412
+460,883
| +68% | +$41.1M |
|
12
Cisco
CSCO
$449B
| $105M | 0.77% |
3,815,448
+173,535
| +5% | +$4.89M |
|
13
Microsoft
MSFT
$2.86T
| $101M | 0.74% |
2,485,803
-424,210
| -15% | -$18.5M |
|
14
Wells Fargo
WFC
$263B
| $98.7M | 0.72% |
1,813,970
-29,933
| -2% | -$1.62M |
|
15
IBM
IBM
$203B
| $98.6M | 0.72% |
642,828
-6,534
| -1% | -$991K |
|
16
iShares MSCI EAFE ETF
EFA
$76.9B
| $91.5M | 0.67% |
1,426,700
+102,361
| +8% | +$6.44M |
|
17
Pfizer
PFE
$140B
| $91.3M | 0.67% |
2,766,566
+219,213
| +9% | +$6.97M |
|
18
Intel
INTC
$480B
| $90.7M | 0.66% |
2,901,437
+170,315
| +6% | +$5.75M |
|
19
Amgen
AMGN
$203B
| $89.9M | 0.66% |
562,552
+104,246
| +23% | +$16.4M |
|
20
SLB Ltd
SLB
$77.5B
| $89.8M | 0.66% |
1,076,649
-97,546
| -8% | -$8.12M |
|
|
DD
21
DELISTED
Du Pont De Nemours E I
DD
| $87.5M | 0.64% |
1,288,594
-33,256
| -3% | -$2.37M |
|
22
Qualcomm
QCOM
$178B
| $84.9M | 0.62% |
1,224,139
+45,568
| +4% | +$3.21M |
|
23
GE Aerospace
GE
$370B
| $84.6M | 0.62% |
711,760
+26,656
| +4% | +$3.17M |
|
24
Honeywell
HON
$76.3B
| $78.7M | 0.57% |
839,551
+83,515
| +11% | +$7.64M |
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $78.5M | 0.57% |
380,426
-37,793
| -9% | -$7.8M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.
- Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
- Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
- Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
- Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
- Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
- Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.
Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.